Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122817
Filing Date
2024-11-07
Accepted
2024-11-07 08:00:23
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20240930.htm   iXBRL 10-Q 1721340
2 EX-31.1 pmvp-ex31_1.htm EX-31.1 16876
3 EX-31.2 pmvp-ex31_2.htm EX-31.2 16635
4 EX-32.1 pmvp-ex32_1.htm EX-32.1 8878
5 EX-32.2 pmvp-ex32_2.htm EX-32.2 9134
  Complete submission text file 0000950170-24-122817.txt   7331079

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pmvp-20240930.xsd EX-101.SCH 1015837
72 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20240930_htm.xml XML 1270662
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 241433267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)